Martin C, Perrin G, Saux P, Papazian L, Gouin F
Department of Anaesthesia and Intensive Care Medicine, Hôpital Nord, Marseille, France.
Intensive Care Med. 1994 Jul;20(6):444-7. doi: 10.1007/BF01710657.
To study the effects of norepinephrine on right ventricular function in patients with hyperdynamic septic shock.
Prospective, open study.
A 15 bed ICU in a university hospital.
9 patients with hyperdynamic septic shock (SBP < 90 mmHg, Cl > or = 4 l.min-1.m-2, SVRI < or = 850 dynes.s.cm-5m-2 and oliguria).
Plasma volume expansion was used to correct a suspected volume deficit and then, norepinephrine infusion was started and titrated to restore systemic blood pressure to the normal range (mean infusion rate: 1.1 +/- 0.2 mcg.kg-1.min-1). Norepinephrine was the only vasoactive agent used in these patients.
A modified Swan-Ganz catheter mounted with a fast response thermistor was inserted in each patient, allowing repeated measurements of RVEDVI and RVEF. At time of inclusion to the study, all but one patient had elevated MPAP (23 +/- 4 mmHg) and RVEF < or = 50%, and all patients had RVEDVI > or = 90 ml.m-2. During norepinephrine infusion, MAP increased from 51 +/- 9 to 89 +/- 10 mmHg (p < 0.0001), PVRI increased from 204 +/- 35 to 286 +/- 63 dynes.s.cm-5.m-2 (p < 0.05), and despite this increase in right ventricular afterload, no detrimental effect in RVEF (36 +/- 11 to 36 +/- 10%) or in RVEDVI (116 +/- 30 to 127 +/- 40 ml.m-2) was observed. A Frank-Starling relationship for the right ventricle was constructed by plotting an index of ventricular performance (RVSWI) against an index of ventricular preload (RVEDVI). A significant upward shift to the right of the relationship was observed during norepinephrine infusion.
It was concluded that norepinephrine exerted a favourable effect on right ventricular function.
研究去甲肾上腺素对高动力型感染性休克患者右心室功能的影响。
前瞻性开放性研究。
某大学医院一间拥有15张床位的重症监护病房。
9例高动力型感染性休克患者(收缩压<90 mmHg,心脏指数≥4 l·min⁻¹·m⁻²,全身血管阻力指数≤850达因·秒·厘米⁻⁵·m⁻²且少尿)。
采用血浆扩容来纠正疑似血容量不足,然后开始输注去甲肾上腺素并进行滴定,以使全身血压恢复至正常范围(平均输注速率:1.1±0.2微克·千克⁻¹·分钟⁻¹)。去甲肾上腺素是这些患者唯一使用的血管活性药物。
为每位患者插入一根装有快速响应热敏电阻的改良Swan-Ganz导管,以便重复测量右心室舒张末期容积指数(RVEDVI)和右心室射血分数(RVEF)。在纳入研究时,除1例患者外,所有患者的平均肺动脉压(MPAP)均升高(23±4 mmHg)且RVEF≤50%,所有患者的RVEDVI≥90 ml·m⁻²。在输注去甲肾上腺素期间,平均动脉压(MAP)从51±9 mmHg升高至89±10 mmHg(p<0.0001),肺血管阻力指数(PVRI)从204±35达因·秒·厘米⁻⁵·m⁻²升高至286±63达因·秒·厘米⁻⁵·m⁻²(p<0.05),尽管右心室后负荷增加,但未观察到对RVEF(从36±11%至变为36±10%)或RVEDVI(从116±30 ml·m⁻²变为127±40 ml·m⁻²)有不利影响。通过绘制心室功能指标(右心室每搏功指数,RVSWI)与心室前负荷指标(RVEDVI)构建右心室的Frank-Starling关系曲线。在输注去甲肾上腺素期间观察到该关系曲线显著向右上方移动。
得出结论,去甲肾上腺素对右心室功能发挥了有益作用。